Suppr超能文献

筛查与监测——原则与实践

Screening and surveillance-principles and practice.

作者信息

Steele Robert Jc

机构信息

University of Dundee, Chair, UK National Screening Committee , Dundee , UK.

出版信息

Br J Radiol. 2018 Oct;91(1090):20180200. doi: 10.1259/bjr.20180200. Epub 2018 Apr 10.

Abstract

Health screening can only be applied to populations, not individuals. For it to be effective, the initial screening test must be acceptable and reasonably accurate, the disease must be treatable with better outcomes when treated early and the harm and cost associated with screening must not outweigh its benefits. Robust evidence is therefore required before systematic screening is implemented. Surveillance implies the testing of people at high risk of disease and is therefore distinct from screening in both scale (smaller) and intensity (greater). In both cases, however, clear information must be provided to potential participants so that they can weigh up the balance of benefit and harm before deciding on whether or not to engage in the process.

摘要

健康筛查仅适用于人群,而非个体。要使其有效,初始筛查测试必须是可接受的且具有合理的准确性,疾病必须在早期治疗时疗效更佳,并且筛查相关的危害和成本不能超过其益处。因此,在实施系统筛查之前需要有力的证据。监测意味着对疾病高危人群进行检测,因此在规模(较小)和强度(更大)方面都与筛查不同。然而,在这两种情况下,都必须向潜在参与者提供清晰的信息,以便他们在决定是否参与该过程之前能够权衡利弊。

相似文献

1
Screening and surveillance-principles and practice.
Br J Radiol. 2018 Oct;91(1090):20180200. doi: 10.1259/bjr.20180200. Epub 2018 Apr 10.
3
A framework provided an outline toward the proper evaluation of potential screening strategies.
J Clin Epidemiol. 2013 Jun;66(6):639-47. doi: 10.1016/j.jclinepi.2012.09.018. Epub 2013 Feb 6.
5
Overview of screening: where we are and where we may be headed.
Epidemiol Rev. 2011;33:1-6. doi: 10.1093/epirev/mxr006. Epub 2011 Jun 27.
7
Trade-off between benefit and harm is crucial in health screening recommendations. Part I: general principles.
J Clin Epidemiol. 2011 Mar;64(3):231-9. doi: 10.1016/j.jclinepi.2010.09.009. Epub 2010 Dec 30.
8
Population based screening - the difficulty of how to do more good than harm and how to achieve it.
Swiss Med Wkly. 2010 Sep 13;140:w13061. doi: 10.4414/smw.2010.13061. eCollection 2010.
10
[Screening induced by health services: impact and consequences. Ethical issues].
Gac Sanit. 2006 Mar;20 Suppl 1:88-95. doi: 10.1157/13086031.

引用本文的文献

1
Contemporary epidemiology of hepatocellular carcinoma: understanding risk factors and surveillance strategies.
J Can Assoc Gastroenterol. 2024 Aug 9;7(5):331-345. doi: 10.1093/jcag/gwae025. eCollection 2024 Oct.
2
Serum-biomarker-based population screening model for hepatocellular carcinoma.
iScience. 2025 Feb 8;28(3):111981. doi: 10.1016/j.isci.2025.111981. eCollection 2025 Mar 21.
3
5
Targeted screening in the UK: A narrow concept with broad application.
Lancet Reg Health Eur. 2022 Apr 14;16:100353. doi: 10.1016/j.lanepe.2022.100353. eCollection 2022 May.

本文引用的文献

1
Montgomery and informed consent: where are we now?
BMJ. 2017 May 12;357:j2224. doi: 10.1136/bmj.j2224.
2
The Role of Genetic Testing in Patients With Breast Cancer: A Review.
JAMA Surg. 2017 Jun 1;152(6):589-594. doi: 10.1001/jamasurg.2017.0552.
4
The benefits and harms of breast cancer screening: an independent review.
Lancet. 2012 Nov 17;380(9855):1778-86. doi: 10.1016/S0140-6736(12)61611-0. Epub 2012 Oct 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验